Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: VidaMed

This article was originally published in The Gray Sheet

Executive Summary

VidaMed: Board of directors seeking replacement for Stuart Edwards, current CEO, president and founder of the Menlo Park, California-based firm. A committee including three top-level VidaMed execs -- Chairman David Douglass and board members Pierre Lamond and Lawrence Mohr -- is conducting a search for a successor to Edwards, who will remain a member of the firm's board of directors. VidaMed says it is making the change in preparation for premarket approval of its TUNA transurethral needle ablation radiofrequency system for treatment of benign prostatic hyperplasia, which the firm expects to receive in 1996...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT005336

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel